| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2023 |
4
| Camac Fund, LP (10% Owner) has filed a Form 4 on AmBase Corp|
Txns:
| Sold 70,000 shares
@ $0.1553, valued at
$10.9k
|
|
| 08/25/2023 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 08/25/2023 |
DEFC14A
| Form DEFC14A - Definitive proxy statement, contested solicitations: |
| 08/23/2023 |
SC 13D
| Camac Fund, LP reports a 4.3% stake in Forte Biosciences, Inc. |
| 08/17/2023 |
PRRN14A
| Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise: |
| 08/03/2023 |
SC 13D/A
| Camac Fund, LP reports a 3.6% stake in Forte Biosciences Inc. |
| 07/27/2023 |
SC 13D/A
| Camac Fund, LP reports a 13.9% stake in Gold Reserve Inc. |
| 07/05/2023 |
SC 13D/A
| Camac Fund, LP reports a 8.6% stake in Forte Biosciences Inc. |
| 06/29/2023 |
4
| Camac Fund, LP (10% Owner) has filed a Form 4 on AmBase Corp|
Txns:
| Sold 202,500 shares
@ $0.15, valued at
$30.4k
|
|
| 06/09/2023 |
4
| Camac Fund, LP (10% Owner) has filed a Form 4 on AmBase Corp|
Txns:
| Sold 15,000 shares
@ $0.15, valued at
$2.3k
|
|
| 05/31/2023 |
SC 13D/A
| Camac Fund, LP reports a 19.7% stake in Ambase Corp. |
| 05/26/2023 |
4
| Camac Fund, LP (10% Owner) has filed a Form 4 on AmBase Corp|
Txns:
| Sold 12,000 shares
@ $0.1, valued at
$1.2k
Sold 1,000,000 shares
@ $0.1, valued at
$100k
|
|
| 05/25/2023 |
PREC14A
| Form PREC14A - Preliminary proxy statements, contested solicitations: |
| 05/25/2023 |
SC 13D/A
| Camac Fund, LP reports a 8.6% stake in Forte Biosciences Inc. |
| 05/10/2023 |
4
| Camac Fund, LP (10% Owner) has filed a Form 4 on AmBase Corp|
Txns:
| Sold 10,000 shares
@ $0.11, valued at
$1.1k
Sold 20,000 shares
@ $0.095, valued at
$1.9k
|
|
| 03/02/2023 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 03/02/2023 |
SC 13G/A
| Camac Fund, LP reports a 13.5% stake in Impac Mortgage Holdings, Inc. |
| 02/21/2023 |
SC 13D/A
| Camac Fund, LP reports a 8.6% stake in Forte Biosciences Inc. |
| 01/30/2023 |
4
| Camac Fund, LP (10% Owner) has filed a Form 4 on AmBase Corp|
Txns:
| Sold 50,000 shares
@ $0.1, valued at
$5k
|
|
| 01/10/2023 |
SC 13D/A
| Camac Fund, LP reports a 0% stake in Pasithea Therapeutics Corp. |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
SC 13D/A
| Camac Fund, LP reports a 6.1% stake in Pasithea Therapeutics Corp. |
| 12/07/2022 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 11/22/2022 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 11/17/2022 |
DEFC14A
| Form DEFC14A - Definitive proxy statement, contested solicitations: |
| 11/08/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/03/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/01/2022 |
SC 13D/A
| Camac Fund, LP reports a 6.7% stake in Pasithea Therapeutics Corp. |
| 10/25/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/13/2022 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 10/12/2022 |
PRRN14A
| Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|